Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MAIT cells regulate NK cell-mediated tumor immunity
Emma V. Petley, Hui‐Fern Koay, Melissa A. Henderson, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Mechanisms of immune activation and regulation: lessons from melanoma
Shelly Kalaora, Adi Nagler, Jennifer A. Wargo, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 4, pp. 195-207
Closed Access | Times Cited: 168
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 84
Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin
Benjamin Ruf, Matthias Bruhns, Sepideh Babaei, et al.
Cell (2023) Vol. 186, Iss. 17, pp. 3686-3705.e32
Open Access | Times Cited: 76
Innate lymphoid cells and innate-like T cells in cancer — at the crossroads of innate and adaptive immunity
Benjamin Ruf, Tim F. Greten, Firouzeh Korangy
Nature reviews. Cancer (2023) Vol. 23, Iss. 6, pp. 351-371
Closed Access | Times Cited: 52
Natural Killer cells at the frontline in the fight against cancer
Loïs Coënon, Mannon Geindreau, François Ghiringhelli, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 16
Mucosal-associated invariant T cells for cancer immunotherapy
Yan-Ruide Li, Kuangyi Zhou, Matthew Wilson, et al.
Molecular Therapy (2022) Vol. 31, Iss. 3, pp. 631-646
Open Access | Times Cited: 44
Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy
Yang Zhou, Miao Li, Kuangyi Zhou, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2266-2266
Open Access | Times Cited: 40
NK Cells in Cancer: Mechanisms of Dysfunction and Therapeutic Potential
Federica Portale, Diletta Di Mitri
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9521-9521
Open Access | Times Cited: 30
Biological functions and therapeutic applications of human mucosal-associated invariant T cells
Ying Fang, Yuning Chen, Shaoqiang Niu, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 1
Double‐negative T cells: Setting the stage for disease control or progression
Teresiama Velikkakam, Kenneth J. Gollob, Walderez O. Dutra
Immunology (2021) Vol. 165, Iss. 4, pp. 371-385
Open Access | Times Cited: 52
Aging unconventionally: γδ T cells, iNKT cells, and MAIT cells in aging
Ayako Kurioka, Paul Klenerman
Seminars in Immunology (2023) Vol. 69, pp. 101816-101816
Open Access | Times Cited: 18
Mucosal-associated invariant T cells in cancer: dual roles, complex interactions and therapeutic potential
Mesut Yiğit, Omer Faruk Basoglu, Derya Unutmaz
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Tumor-Associated Inflammation: The Tumor-Promoting Immunity in the Early Stages of Tumorigenesis
Qing Bi, Jiyue Wu, Xuemeng Qiu, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 28
Reprogramming and redifferentiation of mucosal-associated invariant T cells reveal tumor inhibitory activity
Chie Sugimoto, Yukie Murakami, Eisuke Ishii, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 21
Weaponizing natural killer cells for solid cancer immunotherapy
Joshua K.M. Wong, Riccardo Dolcetti, Handoo Rhee, et al.
Trends in cancer (2022) Vol. 9, Iss. 2, pp. 111-121
Open Access | Times Cited: 21
Potent Immunomodulators Developed from an Unstable Bacterial Metabolite of Vitamin B2 Biosynthesis
Jeffrey Y. W. Mak, Ryan J. D. Rivero, Huy N. Hoang, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 31
Open Access | Times Cited: 4
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy
Chen Chen, Peng Han, Yanping Qing
Autoimmunity Reviews (2024) Vol. 23, Iss. 6, pp. 103579-103579
Closed Access | Times Cited: 4
Tissue-resident immune cells: from defining characteristics to roles in diseases
Jia Li, Xiao Chu, Chunxiang Li, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Circulating Soluble Factors and T-Cell Subsets as Immunological Predictors of Therapy Response in Human Cutaneous Leishmaniasis
Amanda Braga Figueiredo, Kátia L.P. Morais, Israel Tojal da Silva, et al.
The Journal of Infectious Diseases (2025)
Closed Access
The microbiota shapes the life trajectory of mucosal-associated invariant T cells
Yan-Ruide Li, Xinyuan Shen, Yichen Zhu, et al.
Trends in Microbiology (2025)
Open Access
Chemical Modulators of Mucosal Associated Invariant T Cells
Jeffrey Y. W. Mak, Ligong Liu, David P. Fairlie
Accounts of Chemical Research (2021) Vol. 54, Iss. 17, pp. 3462-3475
Open Access | Times Cited: 27
Deep Immunophenotyping of Human Whole Blood by Standardized Multi-parametric Flow Cytometry Analyses
Jian Gao, Yali Luo, Helian Li, et al.
Phenomics (2023) Vol. 3, Iss. 3, pp. 309-328
Open Access | Times Cited: 10
The Tumor Immune Microenvironment plays a Key Role in Driving the Progression of Cholangiocarcinoma
Ye Zhang, Haijiao Yan, Jun Wu
Current Cancer Drug Targets (2024) Vol. 24, Iss. 7, pp. 681-700
Closed Access | Times Cited: 3
MAIT cells are associated with responsiveness to neoadjuvant immunotherapy in COPD‐associated NSCLC
Yanze Yin, Ao Zeng, Abudumijiti Abuduwayiti, et al.
Cancer Medicine (2024) Vol. 13, Iss. 6
Open Access | Times Cited: 3
Deciphering the Pyroptosis-Related Prognostic Signature and Immune Cell Infiltration Characteristics of Colon Cancer
Ran Wei, Shuofeng Li, Guanhua Yu, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top